Skip to main content
Download PDF

Direct hemoperfusion with polymyxin B immobilized fiber for abdominal sepsis in Europe

Surgery Today volume 41, Article number: 754 (2011) Cite this article

Abstract

Since direct hemoperfusion with polymyxin B immobilized fiber (PMX-DHP) received its product certification for use in Europe in 1998, several prospective randomized controlled trials (RCTs) have been conducted in European countries. The first RCT, performed in six European academic medical centers in 2005, concluded that PMX-DHP is associated with improved hemodynamic status and cardiac function. Subsequently, a meta-analysis of PMX-DHP was presented in Italy in 2007. This systematic review found positive effects of PMX-DHP on mean arterial pressure and dopamine/ dobutamine use, PaO2/FiO2 ratio, endotoxin removal, and mortality. However, like most trials on extracorporeal therapies, none of the studies was double-blinded. The EUPHAS study, a multicenter RCT performed in ten Italian intensive care units in 2009, found that PMX-DHP improved 28-day survival, blood pressure, vasopressor requirement, and degree of organ failure. However, investigators in Belgium and Canada pointed out that there was no statistical difference in 28-day survival. Two more RCTs, the ABDO-MIX and EUPHRATES studies, the primary end points of which are 28-day mortality, were started in Europe and the United States at the end of 2010. We are hoping that these RCTs will resolve this issue.

References

  1. Angus D, Wax R. Epidemiology of sepsis: an update. Crit Care Med 2001;29(7 suppl):S109–S116.

    PubMed  Article  CAS  Google Scholar 

  2. Marshall J, Foster D, Vincent J, Cook D, Cohen J, Dellinger R, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004;190:527–534.

    PubMed  Article  CAS  Google Scholar 

  3. Manchu S, Feinstein D, Kumar A, Kumar A. Novel therapies for sepsis: antiendotoxin therapies. Expert Opin Investig Drugs 2002;11:1795–1812.

    Article  Google Scholar 

  4. Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 1991;324:429–436.

    PubMed  Article  CAS  Google Scholar 

  5. McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med 1994;121:1–5.

    PubMed  CAS  Google Scholar 

  6. Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 2003;7:108–114.

    PubMed  Article  CAS  Google Scholar 

  7. Nakamura T, Ushiyama C, Suzuki Y, Inoue T, Shoji H, Shimada N, et al. Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillinresistant staphylococcus aureus. J Hosp Infect 2003;53:58–63.

    PubMed  Article  CAS  Google Scholar 

  8. Nakamura T, Kawagoe Y, Matsuda T, Ueda Y, Koide H. Effects of polymyxin B-immobilized fiber on urinary N-acetyl-B-glucosaminidase in patients with severe sepsis. ASAIO J 2004;50:563–567.

    PubMed  Article  CAS  Google Scholar 

  9. Nakamura T, Ebihara I, Shoji H, Ushiyama C, Suzuki S, Koide H. Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor-4 and betathromboglobulin. Inflamm Res 1999;48:171–175.

    PubMed  Article  CAS  Google Scholar 

  10. Nakamura T, Ushiyama C, Suzuki Y, Shoji H, Shimada N, Koide H. Hemoperfusion with polymyxin-B immobilized fiber for urinary albumin excretion in septic patients with trauma. ASAIO J 2002;48:244–248.

    PubMed  Article  CAS  Google Scholar 

  11. Nakamura T, Ushiyama C, Suzuki Y, Osada S, Inoue T, Shoji H, et al. Hemoperfusion with polymyxin-B immobilized fiber in septic patients with methicillin-resistant staphylococcus aureusassociated glomerulonephritis. Nephron Clin Pract 2003;94:c33–c39.

    PubMed  Article  CAS  Google Scholar 

  12. Nakamura T, Kawagoe Y, Matsuda T, Koide H. Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis. Intensive Care Med 2004;30:1838–1841.

    PubMed  Article  Google Scholar 

  13. Nemoto H, Nakamoto H, Okada H, Sugahara S, Moriwaki K, Arai M, et al. Newly developed polymyxin B-immobilized fibers improve the survival of patients with sepsis. Blood Purif 2001;19:361–369.

    PubMed  Article  CAS  Google Scholar 

  14. Suzuki H, Nemoto H, Nakamoto H, Okada H, Sugahara S, Kanno Y, et al. Continuous hemodiafiltration with polymyxin B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. Ther Apher 2002;6:234–240.

    PubMed  Article  CAS  Google Scholar 

  15. Nakamura T, Ebihara I, Shimada N, Suzuki S, Ushiyama C, Shoji H, et al. Effects of hemoperfusion with polymyxin Bimmobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock. J Infect 1998;37:241–247.

    PubMed  Article  CAS  Google Scholar 

  16. Nakamura T, Ebihara I, Shimada N, Koide H. Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion and polymyxin B immobilized fiber. Intensive Care Med 1998;24:1272–1276.

    PubMed  Article  CAS  Google Scholar 

  17. Nakamura T, Kawagoe Y, Matsuda T, Shoji H, Ueda Y, Tamura N, et al. Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients. Blood Purif 2004;22:256–260.

    PubMed  Article  CAS  Google Scholar 

  18. Nakamura T, Kawagoe Y, Sukuzi T, Shoji H, Ueda Y, Kobayashi N, et al. Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock. Blood Purif 2005;23:417–420.

    PubMed  Article  CAS  Google Scholar 

  19. Shimada N, Nakamura T, Takayashi Y, Tanaka A, Shoji H, Sekizuka K, et al. Effects of polymyxin B-immobilized fiber on serum phosphate concentrations in patients with sepsis. Nephron 2000;86:359–360.

    PubMed  Article  CAS  Google Scholar 

  20. Tani T, Hanasawa K, Endo Y, Yoshioka T, Kodama M, Kaneko M, et al. Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin-B immobilized column. Artif Organs 1998;22:1038–1044.

    PubMed  Article  CAS  Google Scholar 

  21. Tojimbara T, Sato S, Nakajima I, Fuchinoue S, Akiba T, Teraoka S. Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure. Ther Apher Dial 2004;8:286–292.

    PubMed  Article  CAS  Google Scholar 

  22. Ueno T, Sugino M, Nemoto H, Shoji H, Kakita A, Watanabe M. Effect over time of endotoxin adsorption therapy in sepsis. Ther Apher Dial 2005;9:128–136.

    PubMed  Article  CAS  Google Scholar 

  23. Uriu K, Osajima A, Kamochi M, Watanabe H, Aibara K, Kaizu K. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am J Kidney Dis 2002;39:937–947.

    PubMed  Article  CAS  Google Scholar 

  24. Kodama M, Tani T, Hanasawa K, Hirata K, Hirasawa H, Oda S, et al. Treatment of sepsis by plasma endotoxin removal: hemoperfusion using a polymyxin-B immobilized column. Innate Immun 1997;4:293–300.

    Article  CAS  Google Scholar 

  25. Novelli G, Ferretti G, Poli L, Pretagostini R, Ruberto F, Perrella SM, et al. Clinical results of treatment of postsurgical endotoxinmediated sepsis with polymyxin-B direct hemoperfusion. Transplant Proc 2010;42:1021–1024.

    PubMed  Article  CAS  Google Scholar 

  26. Mitaka C, Tsuchida N, Kamada K, Nakajima N, Imai T, Sasaki S. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock. Shock 2009;32:478–483.

    PubMed  Article  CAS  Google Scholar 

  27. Kumagai T, Takeyama N, Yabuki T, Harada M, Miki Y, Kanou H, et al. Apheresis of activated leukocytes with an immobilized polymyxin B filter in septic patients. Shock 2010;34:461–466.

    PubMed  Article  CAS  Google Scholar 

  28. Nemoto H, Nakamoto H, Okada H, Sugahara S, Moriwaki K, Arai M, et al. Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 2001;19:361–368.

    PubMed  Article  CAS  Google Scholar 

  29. Ueno T, Ikeda K, Ikeda K, Taniuchi H, Suda S, Yeung MY, et al. HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP. J Surg Res 2009 [Epub ahead of print]. PMID: 20338589.

  30. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248–251.

    PubMed  Article  CAS  Google Scholar 

  31. Suda K, Takeuchi H, Ishizaka A, Kitagawa Y. High-mobility-group box chromosomal protein 1 as a new target for modulating stress response. Surg Today 2010;40:592–601.

    PubMed  Article  CAS  Google Scholar 

  32. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004;101:296–301.

    PubMed  Article  CAS  Google Scholar 

  33. Suda K, Kitagawa Y, Ozawa S, Saikawa Y, Ueda M, Ebina M, et al. Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis. World J Surg 2006;30:1755–1762.

    PubMed  Article  Google Scholar 

  34. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004;170:1310–1316.

    PubMed  Article  Google Scholar 

  35. Sakamoto Y, Mashiko K, Matsumoto H, Hara Y, Kutsukata N, Yamamoto Y. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients. ASAIO J 2007;53:324–328.

    PubMed  Article  CAS  Google Scholar 

  36. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005;23:400–405.

    PubMed  Article  CAS  Google Scholar 

  37. Cohen J, McConnell JS. Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay. J Infect Dis 1984;150:916–924.

    PubMed  Article  CAS  Google Scholar 

  38. Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis; a systematic review. Crit Care 2007;11:R47.

    PubMed  Article  Google Scholar 

  39. Ono S, Tsujinomoto H, Matsumoto A, Ikuta S, Kinoshita M, Michizuki H. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with polymyxin B immobilized fiber. Am J Surg 2004;188:150–156.

    PubMed  Article  CAS  Google Scholar 

  40. Tsujimoto H, Ono S, Hiraki S, Majima T, Kawarabayashi N, Sugasawa H, et al. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+CD14+ monocytes in patients with septic shock. J Endotoxin Res 2004;10:229–237.

    PubMed  CAS  Google Scholar 

  41. Tsushima K, Kubo K, Koizumi T, Yamamoto H, Fujimoto K, Hora K, et al. Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory. J Clin Apheresis 2002;17:97–102.

    PubMed  Article  Google Scholar 

  42. Ikeda T, Ikeda K, Nagura M, Taniuchi H, Matsushita M, Kiuchi S, et al. Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure. Ther Apher Dial 2004;8:293–298.

    PubMed  Article  CAS  Google Scholar 

  43. Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, et al. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Ther Apher Dial 2006;10:12–18.

    PubMed  Article  CAS  Google Scholar 

  44. Casella G, Monti G, Terzi V, Pulici M, Ravizza A, Vesconi S. Nonconventional therapies in refractory septic shock: clinical experience with polymyxin B (in Italian). Minerva Anestesiol 2006;72(suppl 1):63–67.

    Google Scholar 

  45. Kushi H, Miki T, Okamoto K, Nakahara J, Saito T, Tanjoh K. Early haemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 2005;9:R653–R661.

    PubMed  Article  Google Scholar 

  46. Nakamura T, Matsuda T, Suzuki Y, Shoji H, Koide H. Polymyxin B-immobilized fiber in patient with sepsis. Dial Transplant 2003;32:602–607.

    Google Scholar 

  47. Tsugawa K, Koyanagi N, Hashizume M, Wada H, Ayukawa K, Akahoshi K, et al. Results of endotoxin absorption after a subtotal resection of the small intestine and a right hemicolectomy for severe superior mesenteric ischemia. Hepatogastroenterology 2002;49:1303–1306.

    PubMed  Google Scholar 

  48. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12.

    PubMed  Article  CAS  Google Scholar 

  49. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock. The EUPHAS randomized controlled trial. JAMA 2009;301:2445–2452.

    PubMed  Article  CAS  Google Scholar 

  50. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536–555.

    PubMed  Article  Google Scholar 

  51. Vincent JL, Moreno R, Takala J, Willatts S, Mendonça AD, Bruininget H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707–710.

    PubMed  Article  CAS  Google Scholar 

  52. Shore S, Nelson DP, Pearl JM, Manning PB, Wong H, Shanley TP, et al. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease Am J Cardiol 2001;88:591–594.

    PubMed  Article  CAS  Google Scholar 

  53. Wernovsky G, Wypij D, Jonas RA, Mayer JE Jr, Hanley FL, Hickey PR, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995;92:2226–2235.

    PubMed  CAS  Google Scholar 

  54. Zuppa AF, Nadkarni V, Davis L, Adamson PC, Helfaer MA, Elliott MR, et al. The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med 2004;32:2318–2322.

    PubMed  CAS  Google Scholar 

  55. Tsujimoto H, Ono S, Hiraki S, Majima T, Kawarabayashi N, Sugasawa H, et al. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+CD14+ monocytes in patients with septic shock. J Endotoxin Res 2004;10:229–237.

    PubMed  CAS  Google Scholar 

  56. Vincent JL. Polymyxin B hemoperfusion and mortality in abdominal septic shock. JAMA 2009;302:1968.

    PubMed  Article  CAS  Google Scholar 

  57. Amaral ACKB. Polymyxin B hemoperfusion and mortality in abdominal septic shock. JAMA 2009;302:1968–1969.

    PubMed  Article  CAS  Google Scholar 

  58. Antonelli M, Giunta F, Ronco C. Polymyxin B hemoperfusion and mortality in abdominal septic shock. JAMA 2009;302:1969–1970.

    Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Surgery, Juntendo Shizuoka Hospital, Juntendo University School of Medicine, 1129 Izunokuni, Shizuoka, 410-2295, Japan

    Koichi Sato, Hiroshi Maekawa, Mutsumi Sakurada, Hajime Orita & Yoshihiro Komatsu

Authors
  1. Koichi Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Maekawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mutsumi Sakurada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hajime Orita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoshihiro Komatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sato, K., Maekawa, H., Sakurada, M. et al. Direct hemoperfusion with polymyxin B immobilized fiber for abdominal sepsis in Europe. Surg Today 41, 754 (2011). https://doi.org/10.1007/s00595-010-4504-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s00595-010-4504-9

Key words

  • Direct hemoperfusion
  • Polymyxin B immobilized fiber
  • PMX-DHP
  • Toraymyxin
  • Randomized controlled trial
  • Meta-analysis